Moolec Science SA (MLEC)
1.35
+0.01
(+0.75%)
USD |
NASDAQ |
May 02, 16:00
1.38
+0.03
(+2.22%)
After-Hours: 20:00
Moolec Science Revenue (Quarterly): 0.2521M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.2521M |
September 30, 2023 | 1.740M |
Date | Value |
---|---|
June 30, 2023 | 0.905M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.2521M
Minimum
Dec 2023
1.740M
Maximum
Sep 2023
0.9657M
Average
0.905M
Median
Jun 2023
Revenue (Quarterly) Benchmarks
Alvotech | 53.39M |
Procaps Group SA | 118.41M |
Sunshine Biopharma Inc | 7.680M |
Bio-Path Holdings Inc | -- |
Palisade Bio Inc | -- |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -1.784M |
Total Expenses (Quarterly) | 2.045M |
EPS Diluted (Quarterly) | -0.05 |
Enterprise Value | 56.72M |
Gross Profit Margin (Quarterly) | 92.05% |
Profit Margin (Quarterly) | -707.4% |
Earnings Yield | -9.63% |